Mechanisms of metastasis and development of resistance to therapy in breast cancer. A clinical case of the effectiveness of ixabepilone in hormone-receptorpositive breast cancer wi...

por A. I. Stukan, A. Y. Goryainova, S. V. Sharov, D. V. Andreev, E. V. Lymar
Publicado em 2021-08-01

Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy aft...

por A. I. Stukan, A. Y. Goryainova, E. V. Lymar, S. V. Sharov, V. V. Antipova
Publicado em 2021-12-01